Fertility preservation for cancer patients. Current options

Minerva Ginecologica

Volumn 63, Issue 6, 2011, Pages 517-530

  Shalom Paz, E ^a   Holzer, H E G ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Fertility Genital neoplasms, female; Fertilization, in vitro

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; FOLLITROPIN; GONADORELIN AGONIST; LUTEINIZING HORMONE;

AGE; CANCER PATIENT; CANCER SURVIVAL; CHEMORADIOTHERAPY; CRYOPRESERVATION; EMBRYO TRANSFER; FEMALE FERTILITY; FEMALE INFERTILITY; GENE MUTATION; HODGKIN DISEASE; HUMAN; INFERTILITY THERAPY; NONHUMAN; OOCYTE; OOPHOPEXY; OVARY DISEASE; OVARY FOLLICLE; OVARY INSUFFICIENCY; OVARY TRANSPLANTATION; PATIENT SAFETY; PREGNANCY; RADIATION DOSE; RADIATION INJURY; REPRODUCTION; REVIEW; SURGICAL TECHNIQUE; TRANSPLANTATION;

CRYOPRESERVATION; EMBRYO, MAMMALIAN; FEMALE; FERTILITY PRESERVATION; HUMANS; INFERTILITY, FEMALE; NEOPLASMS; OOCYTES; OVARY; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 84055176616     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. Bleyer WA. The impact of childhood cancer on the United States and the world. CA Cancer J Clin 1990; 40:355-67.
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
3. Wallace WH, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol 2005,6:209-18. (Pubitemid 40450712)
4. National Cancer Institute. Cencer Trends Progress Report 2009/2010 Update [Internet]. [cited 2011 October 11]. Available at: http://progressreport. cancer.gov/doc
5. Elizur SE, Chian RC, Pineau CA, Son WY, Holzer HE, Huang JY et al. Fertility preservation treatment for young women with autoimmune diseases facing treatment with gonadotoxic agents. Rheumatology (Oxford) 2008; 47:1506-9.
6. Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004;364:1405-10. (Pubitemid 39370715)
7. Tulandi T, Al-Shahrani AA. Laparoscopic fertility preservation. Obstet Gynecol Clin North Am 2004;31:611-8. (Pubitemid 39164179)
8. Fertility preservation and reproduction in cancer patients. Fertil Steril 2005;83:1622-8.
9. Oktay K. An individualized approach to fertility preservation in women with cancer. J Support Oncol 2006;4:181-2, 184.
10. Oktay K, Cil AP, Bang H. Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril 2006;86:70-80. (Pubitemid 43962981)
11. Rudick B, Opper N, Paulson R, Bendikson K, Chung K. The status of oocyte cryopreservation in the United States. Fertil Steril 2010;94:2642-6.
12. Donnez J, Dolmans MM. Cryopreservation and transplantation of ovarian tissue. Clin Obstet Gynecol 2010;53:787-96.
13. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006;24:2917-31. (Pubitemid 46655598)
14. Tulandi T, Huang JY, Tan SL. Preservation of female fertility: an essential progress. Obstet Gynecol 2008;112:1160-72.
15. Meirow D, Biederman H, Anderson RA, Wallace WH. Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol 2010;53:727-39.
16. Knopman JM, Papadopoulos EB, Grifo JA, Fino ME, Noyes N. Surviving childhood and reproductive-age malignancy: effects on fertility and future parenthood. Lancet Oncol 2010;11:490-8.
17. Fleischer RT, Vollenhoven BJ, Weston GC. The effects of chemotherapy and radiotherapy on fertility in premenopausal women. Obstet Gynecol Surv 2011;66:248-54.
18. Meirow D, Epstein M, Lewis H, Nugent D, Gosden RG. Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum Reprod 2001;16:632-7. (Pubitemid 32293787)
19. Ataya K, Moghissi K. Chemotherapy-induced premature ovarian failure: mechanisms and prevention. Steroids 1989;54:607-26. (Pubitemid 20083182)
20. Ataya KM, Valeriote FA, Ramahi-Ataya AJ. Effect of cyclophosphamide on the immature rat ovary. Cancer Res 1989;49:1660-4. (Pubitemid 19108383)
21. Sklar CA, Mertens AC, Mitby P, Whitton J, Stovall M, Kasper C et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst 2006,98.890-6.
22. te Velde ER, Scheffer GJ, Dorland M, Broekmans FJ, Fauser BC. Developmental and endocrine aspects of normal ovarian aging. Mol Cell Endocrinol 1998;145:67-73. (Pubitemid 29003179)
23. Gosden RG. Follicular status at the menopause. Hum Reprod 1987;2:617-21.
24. Rodriguez-Wallberg KA, Oktay K. Fertility preservation medicine: options for young adults and children with cancer. J Pediatr Hematol Oncol 2010;32:390-6.
25. Revel A, Revel-Vilk S. Fertility preservation in young cancer patients. J Hum Reprod Sci 2010;3:2-7.
26. George K, Kamath MS. Fertility and age. J Hum Reprod Sci 2010;3:121-3.
27. Frattarelli JL, Levi AJ, Miller BT, Segars JH. A prospective assessment of the predictive value of basal antral follicles in in vitro fertilization cycles. Fertil Steril 2003;80:350-5. (Pubitemid 36959793)
28. La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 2010;16:113-30.
29. Oktay K, Oktem O. Fertility preservation medicine: a new field in the care of young cancer survivors. Pediatr Blood Cancer 2009;53:267-73.
30. Oktem O, Oktay K. Fertility preservation for breast cancer patients. Semin Reprod Med 2009;27:486-92.
31. Gupta PB, Proia D, Cingoz O, Weremowicz J, Naber SP, Weinberg RA et al. Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers. Cancer Res 2007;67:2062-71. (Pubitemid 46424224)
32. Shalom-Paz E, Almog B, Shehata F, Huang J, Holzer H, Chian RC et al. Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification. Reprod Biomed Online 2010;21:566-71.
33. Holzer HE, Tan SL. Fertility preservation in oncology. Minerva Ginecol 2005;57:99-109. (Pubitemid 43942486)
34. Blumenfeld Z. How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries. Oncologist 2007;12:1044-54. (Pubitemid 350007016)
35. Meistrich ML, Shetty G. Hormonal suppression for fertility preservation in males and females. Reproduction 2008;136:691-701.
36. Badawy A, Elnashar A, El-Ashry M, Shahat M. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil Steril 2009;91:694-7.
37. Del Mastro L, Catzeddu T, Boni L, Bell C, Sertoli MR, Bighin C et al. Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients. Ann Oncol 2006;17:74-8. (Pubitemid 43033843)
38. Oktay K, Sonmezer M, Oktem O, Fox K, Emons G, Bang H. Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapyinduced gonadal injury. Oncologist 2007;12:1055-66. (Pubitemid 350007017)
39. Nitzschke M, Raddatz J, Bohlmann MK, Stute P, Strowitzki T, von Wolff M. GnRH analogs do not protect ovaries from chemotherapy-induced ultrastructural injury in Hodgkin's lymphoma patients. Arch Gynecol Obstet 2010;282:83-8.
40. Kim MR, Tilly JL. Current concepts in Bcl-2 family member regulation of female germ cell development and survival. Biochim Biophys Acta 2004;1644:205-10. (Pubitemid 38281276)
41. Kim JH, Lee SY, Oh SY, Han SI, Park HG, Yoo MA et al. Methyl jasmonate induces apoptosis through induction of Bax/Bcl-XS and activation of caspase-3 via ROS production in A549 cells. Oncol Rep 2004;12:1233-8.
42. Rasool N, Rose PG. Fertility-preserving surgical procedures for patients with gynecologic malignancies. Clin Obstet Gynecol 2010;53:804-14.
43. Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 2001;7:535-43. (Pubitemid 33069611)
44. Gosden RG, Baird DT, Wade JC, Webb R. Restoration of fertility to oophorectomized sheep by ovarian autografts stored at -196 degrees C. Hum Reprod 1994;9:597-603. (Pubitemid 24132333)
45. Bordes A, Lornage J, Demirci B, Franck M, Courbiere B, Guerin JF et al. Normal gestations and live births after orthotopic autograft of vitrified-warmed hemi-ovaries into ewes. Hum Reprod 2005;20:2745-8. (Pubitemid 41487628)
46. Almodin CG, Minguetti-Camara VC, Meister H, Ferreira JO, Franco RL, Cavalcante AA et al. Recovery of fertility after grafting of cryopreserved germinative tissue in female rabbits following radiotherapy. Hum Reprod 2004;19:1287-93. (Pubitemid 38807698)
47. Meirow D, Levron J, Eldar-Geva T, Hardan I, Fridman E, Zalel Y et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 2005;353:318-21. (Pubitemid 41058339)
48. Demeestere I, Simon P, Emiliani S, Delbaere A, Englert Y. Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin's disease. Oncologist 2007;12:1437-42.
49. von Wolff M, Donnez J, Hovatta O, Keros V, Maltaris T, Montag M et al. Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy - a technique in its infancy but already successful in fertility preservation. Eur J Cancer 2009;45:1547-53.
50. Meirow D, Hardan I, Dor J, Fridman E, Elizur S, Ra'anani H et al. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod 2008;23:1007-13. (Pubitemid 351757322)
51. Shaw J, Trounson A. Oncological implications in the replacement of ovarian tissue. Hum Reprod 1997;12:403-5. (Pubitemid 27156422)
52. Bedaiwy MA, Falcone T. Whole ovary transplantation. Clin Obstet Gynecol 2010;53:797-803.
53. Poirot CJ, Martelli H, Genestie C, Golmard JL, Valteau-Couanet D, Helardot P et al. Feasibility of ovarian tissue cryopreservation for prepubertal females with cancer. Pediatr Blood Cancer 2007;49:74-8. (Pubitemid 46847071)
54. Silber S, Kagawa N, Kuwayama M, Gosden R. Duration of fertility after fresh and frozen ovary transplantation. Fertil Steril 2010;94:2191-6.
55. Lee DM, Yeoman RR, Battaglia DE, Stouffer RL, Zelinski-Wooten MB, Fanton JW et al. Live birth after ovarian tissue transplant. Nature 2004;428:137-8. (Pubitemid 38374297)
56. Hovatta O, Silye R, Krausz T, Abir R, Margara R, Trew G et al. Cryopreservation of human ovarian tissue using dimethylsulphoxide and propanediol-sucrose as cryoprotectants. Hum Reprod 1996,11:1268-72. (Pubitemid 26245329)
57. Oktay K, Karlikaya G. Ovarian function after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med 2000;342:1919. (Pubitemid 30419063)
58. Andersen CY, Rosendahl M, Byskov AG, Loft A, Ottosen C, Dueholm M et al. Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum Reprod 2008;23:2266-72.
59. Silber SJ, Grudzinskas G, Gosden RG. Successful pregnancy after microsurgical transplantation of an intact ovary. N Engl J Med 2008;359:2617-8.
60. Liu J, Van der Elst J, Van den Broecke R, Dhont M. Early massive follicle loss and apoptosis in heterotopically grafted newborn mouse ovaries. Hum Reprod 2002;17:605-11. (Pubitemid 34232428)
61. Demeestere I, Delbaere A, Gervy C, Van Den Bergh M, Devreker F, Englert Y. Effect of preantral follicle isolation technique on in-vitro follicular growth, oocyte maturation and embryo development in mice. Hum Reprod 2002;17:2152-9.
62. Oktay K, Nugent D, Newton H, Salha O, Chatterjee P, Gosden RG. Isolation and characterization of primordial follicles from fresh and cryopreserved human ovarian tissue. Fertil Steril 1997;67:481-6. (Pubitemid 27085962)
63. Abir R, Roizman P, Fisch B, Nitke S, Okon E, Orvieto R et al. Pilot study of isolated early human follicles cultured in collagen gels for 24 hours. Hum Reprod 1999;14:1299-301. (Pubitemid 29224910)
64. Huang JY, Tulandi T, Holzer H, Tan SL, Chian RC. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil Steril 2008;89:567-72. (Pubitemid 351335045)
65. Revel A, Revel-Vilk S, Aizenman E, Porat-Katz A, Safran A, Ben-Meir A et al. At what age can human oocytes be obtained? Fertil Steril 2009;92:458-63.
66. Sauvat F, Capito C, Sarnacki S, Poirot C, Bachelot A, Meduri G et al. Immature cryopreserved ovary restores puberty and fertility in mice without alteration of epigenetic marks. PLoS One 2008;3:e1972.
67. Vajta G KMVP. Disadvantages and benefits of vitrification. In: Tucker MJ, Liebermann J, editors. Vitrification in assisted reproduction A user's manual and troubleshooting guide. London: Informa UK; 2007. p. 33-44.
68. Trounson A, Mohr L. Human pregnancy following cryopreservation, thawing and transfer of an eight-cell embryo. Nature 1983;305:707-9. (Pubitemid 13021518)
69. Zeilmaker GH, Alberda AT, van Gent I, Rijkmans CM, Drogendijk AC. Two pregnancies following transfer of intact frozen-thawed embryos. Fertil Steril 1984;42:293-6. (Pubitemid 14093055)
70. Gnoth C, Maxrath B, Skonieczny T, Friol K, Godehardt E, Tigges J. Final ART success rates: a 10 years survey. Hum Reprod 2011;26:2239-46.
71. Nygren KG, Sullivan E, Zegers-Hochschild F, Mansour R, Ishihara O, Adamson GD et al. International Committee for Monitoring Assisted Reproductive Technology (ICMART) world report: assisted reproductive technology 2003. Fertil Steril 2011;95:2209-22, 2222 e2201-2217.
72. Nyboe Andersen A, Goossens V, Bhattacharya S, Ferraretti AP, Kupka MS, de Mouzon J et al. Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE: ESHRE. The European IVF Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod 2009;24:1267-87.
73. Kolibianakis EM, Venetis CA, Tarlatzis BC. Cryopreservation of human embryos by vitrification or slow freezing: which one is better? Curr Opin Obstet Gynecol 2009;21:270-4.
74. Riggs R, Mayer J, Dowling-Lacey D, Chi TF, Jones E, Oehninger S. Does storage time influence post-thaw survival and pregnancy outcome? An analysis of 11,768 cryopreserved human embryos. Fertil Steril 2010;93:109-15.
75. Herrero L, Martinez M, Garcia-Velasco JA. Current status of human oocyte and embryo cryopreservation. Curr Opin Obstet Gynecol 2011;23:245-50.
76. Ata B, Chian RC, Tan SL. Cryopreservation of oocytes and embryos for fertility preservation for female cancer patients. Best Pract Res Clin Obstet Gynaecol 2010;24:101-12.
77. Porcu E, Fabbri R, Seracchioli R, Ciotti PM, Magrini O, Flamigni C, Birth of a healthy female after intracytoplasmic sperm injection of cryopreserved human oocytes. Fertil Steril 1997;68:724-6. (Pubitemid 27454338)
78. Chian RC, Huang JY, Gilbert L, Son WY, Holzer H, Cui SJ et al. Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes. Fertil Steril 2009,91:2391-8.
79. Kim TJ, Laufer LR, Hong SW. Vitrification of oocytes produces high pregnancy rates when carried out in fertile women. Fertil Steril 2010;93:467-74.
80. Cobo A, Diaz C. Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril 2011;96:277-85.
81. Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod Biomed Online 2009;18:769-76.
82. Yager JD, Davidson NE: Estrogen carcinogenesis in breast cancer. N Engl J Med 2006;354:270-82.
83. Gupta PB, Kuperwasser C. Contributions of estrogen to ER-negative breast tumor growth. J Steroid Biochem Mol Biol 2006;102:71-8. (Pubitemid 44750648)
84. Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol 2008;26:2630-5.
85. Oktay K, Turkcuoglu I, Rodriguez-Wallberg KA. GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation. Reprod Biomed Online 2010;20:783-8.
86. Holzer H, Lin Tan S. Fertility preservation in oncology. Minerva Ginecol 2005,57:99-109. (Pubitemid 43942486)
87. Rao G, Chian R, Son W, Gilbert L, Tan S. Fertility preservation in women undergoing cancer treatment. Lancet 2004;363:1829-30. (Pubitemid 38698392)
88. Son WY, Chung JT, Chian RC, Herrero B, Demirtas E, Elizur S et al. A 38 h interval between hCG priming and oocyte retrieval increases in vivo and in vitro oocyte maturation rate in programmed IVM cycles. Hum Reprod 2008;23:2010-6.
89. Son WY, Chung JT, Herrero B, Dean N, Demirtas E, Holzer H et al. Selection of the optimal day for oocyte retrieval based on the diameter of the dominant follicle in hCG-primed in vitro maturation cycles. Hum Reprod 2008,23:2680-5.
90. Oktay K, Demirtas E, Son WY, Lostritto K, Chian RC, Tan SL. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation. Fertil Steril 2008;89:228 e219-222.
91. Demirtas E, Elizur SE, Holzer H, Gidoni Y, Son WY, Chian RC et al. Immature oocyte retrieval in the luteal phase to preserve fertility in cancer patients. Reprod Biomed Online 2008;17:520-3.
92. Cao YX, Xing Q, Li L, Cong L, Zhang ZG, Wei ZL et al. Comparison of survival and embryonic development in human oocytes cryopreserved by slow-freezing and vitrification. Fertil Steril 2009;92:1306-11.
93. Chian R, Gilbert L, Huang J, Demirtas E, Holzer H, Benjamin A et al. Live birth after vitrification of in vitro matured human oocytes. Fertil Steril 2009;91:372-6.
94. Soderstrom-Anttila V, Makinen S, Tuuri T, Suikkari AM. Favourable pregnancy results with insemination of in vitro matured oocytes from unstimulated patients. Hum Reprod 2005;20:1534-40. (Pubitemid 40852244)
95. Reinblatt SL, Buckett W. In vitro maturation for patients with polycystic ovary syndrome. Semin Reprod Med 2008;26:121-6.
96. Buckett WM, Chian RC, Holzer H, Dean N, Usher R, Tan SL. Obstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization, and intracytoplasmic sperm injection. Obstet Gynecol 2007;110:885-91. (Pubitemid 47508755)
97. Zhang XY, Ata B, Son WY, Buckett WM, Tan SL, Ao A. Chromosome abnormality rates in human embryos obtained from in-vitro maturation and IVF treatment cycles. Reprod Biomed Online 2010;21:552-9.
98. Moria A, Das M, Shehata F, Holzer H, Son WY, Tulandi T. Ovarian reserve and oocyte maturity in women with malignancy undergoing in vitro maturation treatment. Fertil Steril 2011;95:1621-3.